s-methylisothiopseudouronium has been researched along with Atrophy in 1 studies
S-methylisothiopseudouronium: inhibits nitric oxide synthase; structure in first source
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, CM | 1 |
| Liu, CH | 1 |
| Chen, LW | 1 |
1 other study available for s-methylisothiopseudouronium and Atrophy
| Article | Year |
|---|---|
Nitric oxide synthase inhibitor ameliorates oral total parenteral nutrition-induced barrier dysfunction.
Topics: Administration, Oral; Animals; Atrophy; Bacterial Translocation; Dextrans; Enzyme Activation; Enzyme | 2000 |